St. Jude Buys Nanostim as Pacemaker Gets EU Approval

St. Jude Medical purchased Nanostim for $123.5 million and said the company’s core technology, a tiny wireless pacemaker implanted entirely inside the heart, won European Union approval.
Bloomberg